Shafiee Mohammad, Habibi Parnian, Sakhabakhsh Mahdi, Mirjani Rohollah, Zahediniya Mohsen, Yousefpour Mitra
Department of Neurology, Faculty of Medicine, AJA University of Medical Science, Tehran, Iran.
Department of Neurology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
J Family Med Prim Care. 2022 Sep;11(9):5626-5632. doi: 10.4103/jfmpc.jfmpc_537_22. Epub 2022 Oct 14.
One of the probable etiologies raised in patients with chronic migraine headaches is stenosis of the lateral venous sinuses of the brain, which is detectable using magnetic resonance venography (MRV). In this study, we decided to observe the effect of adding aspirin to anti-migraine medicines on the severity of headache in patients with chronic migraine headaches with lateral venous sinus stenosis in MRV.
The study was a double-blind randomized clinical trial. Patients were included in the study in two groups including 30 people. The first group was treated with propranolol and nortriptyline, and the second group was treated with propranolol, nortriptyline, and aspirin. The severity of headache, number of headaches during one month, and duration of a headache before treatment and one, two, and three months after treatment were examined. Data were analyzed utilizing SPSS software version 19 and statistical tests like -test, Chi-squared test, Paired -test, and repeated measure.
The results showed that the mean severity of headache in the second group was significantly lower than the first group two months after treatment ( = 0.003) and three months after treatment ( = 0.002). Additionally, the number of headaches ( = 0.001) and duration of headache ( = 0.043) were significantly lower in the second group than the first group in the first three months after treatment. No statistically significant difference was observed between the frequency distribution of nausea/vomiting in the two groups.
The addition of aspirin to anti-migraine medicines is effective in improving the severity of headache in patients with migraine with lateral venous sinus stenosis of the brain.
慢性偏头痛患者可能的病因之一是脑外侧静脉窦狭窄,这可通过磁共振静脉血管造影(MRV)检测出来。在本研究中,我们决定观察在抗偏头痛药物中添加阿司匹林对经MRV检测有外侧静脉窦狭窄的慢性偏头痛患者头痛严重程度的影响。
该研究为双盲随机临床试验。患者被分为两组纳入研究,每组30人。第一组接受普萘洛尔和去甲替林治疗,第二组接受普萘洛尔、去甲替林和阿司匹林治疗。对治疗前以及治疗后1个月、2个月和3个月的头痛严重程度、每月头痛次数以及一次头痛的持续时间进行了检查。使用SPSS 19版软件进行数据分析,并采用t检验、卡方检验、配对t检验和重复测量等统计检验方法。
结果显示,治疗2个月后(P = 0.003)和治疗3个月后(P = 0.002),第二组的平均头痛严重程度显著低于第一组。此外,治疗后的前三个月,第二组的头痛次数(P = 0.001)和头痛持续时间(P = 0.043)显著低于第一组。两组恶心/呕吐的频率分布之间未观察到统计学上的显著差异。
在抗偏头痛药物中添加阿司匹林可有效改善患有脑外侧静脉窦狭窄的偏头痛患者的头痛严重程度。